Disulfide exchange in domain 2 of CD4 is required for entry of HIV-I

Nature Immunology

Volumn 3, Issue 8, 2002, Pages 727-732

  Matthias, Lisa J ^a   Yam, Patricia T W ^a   Jiang, Xing Mai ^a   Vandegraaff, Nick ^b   Li, Peng ^b   Poumbourios, Pantelis ^a   Donoghue, Neil ^a   Hogg, Philip J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ARSENIC; CD4 ANTIGEN; DISULFIDE; DITHIOL DERIVATIVE; IMMUNOGLOBULIN RECEPTOR; THIOL; THIOREDOXIN;

ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DISULFIDE BOND; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROPHILICITY; IMMUNE SYSTEM; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN SECRETION; T LYMPHOCYTE; VIRUS TRANSMISSION;

ANTIGENS, CD4; ARSENICALS; BIOTIN; CD4-POSITIVE T-LYMPHOCYTES; CYSTEINE; GLUTATHIONE; HIV-1; HUMANS; IMMUNOBLOTTING; LYSINE; MALEIMIDES; MUTATION; OXIDATION-REDUCTION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, HIV; SUCCINIMIDES; SULFHYDRYL COMPOUNDS; THIOREDOXIN;

EID: 0036341983     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni815     Document Type: Article

References (50)

1. Interactions between MHC molecules and co-receptors of the TCR
2. HIV-I entry inhibitors in the side pocket
3. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: A new member of the immunoglobulin gene family
4. Characterization of a soluble form of human CD4
5. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains
6. Crystal structure of an HIV-binding recombinant fragment of human CD4
7. 2-terminal domains
8. The crystallographically determined structures of atypical strained disulfides engineered into subtilisin
9. A new force field for molecular mechanical simulation of nucleic acids and proteins
10. 1 with zero, one, and two intact disulfide bonds
11. Junctional plasma membrane domains isolated from aggregating Dictyostelium discoideum amebae
12. Redox control of exofacial protein thiols/disulfides by protein disulfide isomerase
13. SRα promoter: An efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat
14. Site-directed mutagenesis of human thioredoxin
15. A soluble form of CD4 (T4) protein inhibits AIDS virus infection
16. Human plasma lecithin-cholesterol acyltransferase. The vicinal nature of cysteine 31 and cysteine 184 in the catalytic site
17. Presence of closely-spaced protein thiols on the surface of mammalian cells
18. Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: Putative inhibitors of HIV-1 integrase
19. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1
20. Determinants of CD4 independence for a human immunodeficiency virus type I variant map outside regions required for coreceptor specificity
21. Redox mechanism as alternative to ligand binding for receptor activation delivering disregulated cellular signals
22. Direct evidence for native CD4 oligomers in lymphoid and monocytoid cells
23. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction
24. Protein anatomy
25. Cyclic cystine peptides. Antiparallel β-sheet conformation for the 20-membered ring in Boc-Cys-Val-Aib-Ala-Leu-Cys-NHMe
26. Cystine peptides
27. Structural diversity in domains of the immunoglobulin superfamily
28. The α-chain of murine CD8 lacks an invariant Ig-like disulfide bond but contains a unique intrachain loop instead
29. Thioredoxin
30. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin: Possible involvement of a dithiol-reduction in the IL-2 receptor induction
31. Identification of a thioredoxin-related protein associated with plasma membranes
32. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway
33. Detection of membrane associated thioredoxin on human cell lines
34. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: Presence in human plasma
35. A human recombinant Fab identifies a human immunodeficiency virus type I-induced conformational change in cell surface-expressed CD4
36. Normal-mode analysis suggests important flexibility between the two N-terminal domains of CD4 and supports the hypothesis of a conformational change in CD4 upon HIV binding
37. Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody
38. + cells
39. Elevation of plasma thioredoxin levels in HIV-infected individuals
40. Chronic elevation of plasma thioredoxin: Inhibition of chemotaxis and curtailment of life expectancy in AIDS
41. N-acetylcysteine: A new approach to anti-HIV therapy
42. HIV-induced cysteine deficiency and T-cell dysfunction - A rationale for treatment with N-acetylcysteine
43. Cystamine potently suppresses in vitro HIV replication in acutely and chronically infected human cells
44. Cystamine inhibits HIV type I replication in cells of monocyte/macrophage and T cell lineages
45. In vitro inhibition of the replication of human immunodeficiency virus type I by β-mercaptoethanol (cysteamine)
46. Treatment of HTLV-III/LAV-infected patients with D-penicillamine
47. Selective inhibition of replication of the AIDS-associated virus HTLV-III/LAV by synthetic D-penicillamine
48. Current evidence and future directions for targeting HIV entry: Therapeutic and prophylactic strategies
49. Synthesis of human immunodeficiency virus DNA in a cell-to-cell transmission model